Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bioorganic and Medicinal Chemistry

Garcia-Junceda, E., Garcia-Garcia, J.F., Bastida, A. and Fernandez-Mayoralas, A. (2004) Bioorganic and Medicinal Chemistry,... [Pg.167]

DeSantis, G., Liu, J., Clark, D.R et al. (2003) Structure-based mutagenesis approaches toward expanding the substrate specificity of D-2-deoxyribose-5-phosphate aldolase. Bioorganic and Medicinal Chemistry, 11, 43-52. [Pg.76]

Lacroix, I., Biton, J. and Azerad, R. (1997) Microbial biotransformation of a synthetic immunomodulating agent, HR325. Bioorganic and Medicinal Chemistry, 5, 1369-1380. [Pg.225]

Jacobsen, J.R., Keatinge-Clay, A.T., Cane, D.E. and Khosla, C. (1998) Precursor-directed biosynthesis of 12-ethyl erythromycin. Bioorganic and Medicinal Chemistry, 6, 1171. [Pg.259]

Lucjan Strekowski was born in Poland. In 1967 he obtained an MS degree in polymer chemistry with distinction from the Mendeleev Institute of Chemistry, Moscow, former USSR, and in 1971 a Ph.D. degree in organic chemistry from the Institute of Chemistry, Polish Academy of Sciences, Warsaw, Poland. In 1972 he was appointed assistant professor and in 1976 promoted to associate professor (Docent) at the Institute of Chemistry, Adam Mickiewicz University, Poznan, Poland. After several stints as visiting scientist at the University of Kansas, USA, the University of Florida, USA, and the Australian National University, in 1984 he accepted the position of assistant professor at the Department of Chemistry, Georgia State University, where he was promoted to associate professor in 1989, and then to professor in 1996. Professor Strekowski has published more than 250 research papers, directed 16 Ph.D. dissertations, and trained more than 40 postdoctoral research associates in the areas of heterocyclic, bioorganic and medicinal chemistry. [Pg.1005]

Kiyoi, T. and Kondo, H. (1998) Bioorganic and Medicinal Chemistry Letters, 8, 2845-2848. [Pg.152]

Karelson, Bioorganic and Medicinal Chemistry, 14, 4987 (2006). QSAR Modeling of the Inhibition of Glycogen Synthase Kinase-3. [Pg.388]

Lopez-Rodriguez, M.L., Ayala, D., Viso, A., Benhamu, B., Fernandez de la Pradilla, R., Zarza, F. and Ramos, J.A. (2004) Synthesis and structure-activity relationships of a new model of arylpiperazines. 7. Study of the influence oflipophilic factors at the terminal amide fragment on 5-HT1A affinity/selectivity. Bioorganic and Medicinal Chemistry, 12, 1551-1557. [Pg.475]

Bosi S, Da Ros T, Castellano S, Banli E, Prato M (2000) Antimycobacterial activity of ionic fullerene derivatives. Bioorganic and Medicinal Chemistry Letters 10 1043-1045. [Pg.258]

Jensen AW, Wilson SR, Schuster DI (1996) Biological applications of fullerenes. Bioorganic and Medicinal Chemistry 4 767-779. [Pg.261]


See other pages where Bioorganic and Medicinal Chemistry is mentioned: [Pg.61]    [Pg.62]    [Pg.82]    [Pg.166]    [Pg.168]    [Pg.189]    [Pg.189]    [Pg.269]    [Pg.270]    [Pg.274]    [Pg.313]    [Pg.313]    [Pg.315]    [Pg.317]    [Pg.18]    [Pg.39]    [Pg.1]    [Pg.111]    [Pg.111]    [Pg.152]    [Pg.157]    [Pg.159]    [Pg.160]    [Pg.161]    [Pg.161]    [Pg.201]    [Pg.201]    [Pg.202]    [Pg.203]    [Pg.359]    [Pg.422]    [Pg.474]    [Pg.3]    [Pg.70]    [Pg.142]    [Pg.272]    [Pg.274]   
See also in sourсe #XX -- [ Pg.154 , Pg.288 ]




SEARCH



Bioorganic

Chemistry and medicine

Medicinal chemistry

© 2024 chempedia.info